2. Academic Validation
  3. Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors

Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors

  • Br J Pharmacol. 2000 Mar;129(6):1057-9. doi: 10.1038/sj.bjp.0703142.
I F Musgrave 1,  E Badoer
Affiliations

Affiliation

  • 1 Department of Medical Laboratory Science, RMIT, Melbourne 3001 Australia. Department of Medicine, Monash University, Clayton, 3168 Australia. ian.musgrave@rmit.edu.au
PMID: 10725251 DOI: 10.1038/sj.bjp.0703142
Abstract

The beta-carboline, harmane (0.1 - 1.0 nmol) produces dose dependent hypotension when microinjected unilaterally into the rostral ventrolateral medulla (RVLM) of the anaesthetized rat. The potency of harmane on blood pressure is similar to that of the imidazoline, clonidine. The hypotensive effects of both clonidine and harmane are reversed by microinjection of the relatively I(1)-receptor selective antagonist efaroxan (20 nmol). These results are consistent with harmane acting at an I(1)-receptor in the RVLM. This is the first report of an endogenous ligand for I(1)-receptors that has central effects on blood pressure.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验，部分功能也使用 Cookies 帮助我们更好地理解您的需求，为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问，请阅读我们的《隐私声明》。

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z